Aging and the Kidney: Possible Mechanisms, Consequences, and Management Strategies
Editat de Stephen Fadem, Ahmed Arslan Yousuf Awan, Emaad Abdel-Rahmanen Limba Engleză Paperback – iul 2026
The second part examines the functional decline in elderly patients and includes subparts on impaired quality of life, sleep quality, fall risk, frailty, depression, and sarcopenia. It also considers unique features of hypertension, diabetes, glomerulonephritis, and peripheral vascular disease. The final part focuses on diagnostic, management, and prevention strategies. The common myths about chronic kidney disease in the elderly are addressed, with particular attention to how a solitary kidney in living donors ages over time. Kidney function and its relationship to neurologic complications, cancers, and cardiovascular disease are explained, along with current treatment approaches, medications, and future directions in the care of elderly patients. This comprehensive work serves as a valuable resource for understanding how aging affects systemic health and offers potential pathways to enhance lifespan and well-being in elderly patients.
- Covers histological, structural, physiological, and functional changes leading to a decline in kidney function with aging
- Summarizes the most up-to-date research on the kidney’s impact on health and lifespan
- Addresses common myths regarding kidney disease in the elderly
- Provides guidance on diagnostic, management, and prevention strategies in kidney health and disease for the aging patient
Preț: 1157.52 lei
Preț vechi: 1218.44 lei
-5% Precomandă
Puncte Express: 1736
Preț estimativ în valută:
204.68€ • 234.77$ • 176.95£
204.68€ • 234.77$ • 176.95£
Carte nepublicată încă
Doresc să fiu notificat când acest titlu va fi disponibil:
Se trimite...
Specificații
ISBN-13: 9780443340697
ISBN-10: 0443340692
Pagini: 450
Dimensiuni: 191 x 235 mm
Editura: ELSEVIER SCIENCE
ISBN-10: 0443340692
Pagini: 450
Dimensiuni: 191 x 235 mm
Editura: ELSEVIER SCIENCE
Cuprins
PART 1 – Mechanisms of aging in the kidney
1. Structure and physiological changes in the aging kidney
2. Models of aging kidney
3. Molecular mechanisms of aging in the kidney
4. The podocyte
5. Epigenetics and the kidney
6. The influence of acute kidney injury on aging
7. Nutritional considerations and aging
8. Proteomics in the kidney
PART 2 – Clinical Consequences
9. Functional impairment in elderly CKD patients
10. Unique characteristics of kidney diseases in the elderly
PART 3 – Management and Prevention
11. How to make a diagnosis of CKD in an elderly individual, since a decline in GFR is expected with normal healthy aging
12. Myths about CKD in the elderly
13. The living donor and aging
14. CNS limitations in the elderly kidney patient
15. Cancer and the kidney in an elderly individual
16. CKD and cardiovascular diseases (CVD) in an elderly individual
17. Benefits of RAAS blockage
18. Newer drugs and CKD
19. Drugs to avoid with geriatric kidney disease
20. Conservative management of ESRD
1. Structure and physiological changes in the aging kidney
2. Models of aging kidney
3. Molecular mechanisms of aging in the kidney
4. The podocyte
5. Epigenetics and the kidney
6. The influence of acute kidney injury on aging
7. Nutritional considerations and aging
8. Proteomics in the kidney
PART 2 – Clinical Consequences
9. Functional impairment in elderly CKD patients
10. Unique characteristics of kidney diseases in the elderly
PART 3 – Management and Prevention
11. How to make a diagnosis of CKD in an elderly individual, since a decline in GFR is expected with normal healthy aging
12. Myths about CKD in the elderly
13. The living donor and aging
14. CNS limitations in the elderly kidney patient
15. Cancer and the kidney in an elderly individual
16. CKD and cardiovascular diseases (CVD) in an elderly individual
17. Benefits of RAAS blockage
18. Newer drugs and CKD
19. Drugs to avoid with geriatric kidney disease
20. Conservative management of ESRD